Psychiatry Brain Aging & Sleep Center | NYU Langone Health
NYU Langone’s Department of Psychiatry features the Center for Sleep and Brain Health, which conducts research in this emerging field.
Psychiatry Research Leadership | NYU Langone Health
Faculty in NYU Langone’s Department of Psychiatry are experts in the scientific investigation of mental health.
Psychiatry Epidemiology and Services Research | NYU Langone Health
Epidemiology research in NYU Langone’s Department of Psychiatry aims to increase understanding of populations’ mental and behavioral health.
Psychiatry Computational Research | NYU Langone Health
NYU Langone’s Department of Psychiatry conducts computational neuroscience research and assesses clinical states in psychiatric disorders.
Alzheimer’s Disease Research Center Research Studies | NYU Langone Health
NYU Langone’s Alzheimer’s Disease Research Center is currently recruiting volunteers for a variety of research studies.
Mood Disorders Research | NYU Langone Health
NYU Langone’s Department of Psychiatry conducts research to better understand and treat mood and cognitive disorders.
Psychiatry Publications | NYU Langone Health
Physician–scientists in NYU Langone’s Department of Psychiatry publish their research in prestigious journals.
Alzheimer’s Disease Research Center Research Spotlight | NYU Langone Health
NYU Langone’s Alzheimer’s Disease Research Center investigators share the problems they research and the techniques they use to study them.
Treatment Of OSA On Sleep-Dependent Memory And Blood Biomarkers In Black Study Participants
The purpose of this research study is assess whether treating sleep apnea affects memory and other brain-related health factors related to Alzheimer’s disease and related dementias (AD). This study is evaluating a new way of starting therapy for obstructive sleep apnea (OSA).
Monitoring outcomes of new disease modifying interventions and optimization of risk assessment in Alzheimer's disease
The purpose of this study is to develop an easier way to predict brain changes that might occur from Alzheimer's treatments, especially those using antibody therapies like Leqembi (Lecanemab). These therapies can occasionally cause brain changes, like swelling or small internal bleeding, which are usually harmless but sometimes can cause symptoms like headaches or confusion. Normally, these changes are monitored with MRI scans. However, we want to see if a simple blood test could serve as a more convenient alternative to MRIs.